From: Advance care planning in progressive neurological diseases: lessons from ALS
Number of interviewees | with ALS/PMA | 16/5 |
---|---|---|
Gender | male/female | 13/8 |
Age (range 36–83 years) | < 55 years | 7 |
55–65 years | 9 | |
> 65 years | 5 | |
Disease onset | limb/bulbar | 17/4 |
Functional stage (when interviewed) | ALS-FRS ≥ 40 (including dysarthriaa) | 5 (1) |
ALS-FRS 31–39 (including dysarthriaa) | 8 (2) | |
ALS-FRS ≤ 30 (including dysarthriaa) | 8 (4) |